NCT03941730 2026-03-05
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer
Mayo Clinic
Phase 2 Active not recruiting
Clinical Trials
16 trialsNCT06179303 2026-02-27
Functional Imaging in Prediction of Response to Abemaciclib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer
University of Washington
Phase 2 Recruiting
NCT01984138 2026-01-28
REVIVE
The Methodist Hospital Research Institute
Phase 2 Active not recruiting
NCT05716516 2026-01-14
ESTHER
Dartmouth-Hitchcock Medical Center
Phase 2 Recruiting
NCT00984399 2025-12-09
Serum Estradiol Levels In Postmenopausal Women With Breast Cancer Receiving Adjuvant Aromatase Inhibitors and Vaginal Estrogen
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT05900895 2025-11-20
PHOEBE
Dartmouth-Hitchcock Medical Center
Phase 1 Recruiting
NCT02238808 2025-06-26
PRESTO
AHS Cancer Control Alberta
Phase 2 Active not recruiting
NCT00080756 2024-08-28
Deslorelin Combined With Low-Dose Add-Back Estradiol and Testosterone in Preventing Breast Cancer in Premenopausal Women Who Are at High Risk for This Disease
City of Hope Medical Center
Phase 2 Active not recruiting
NCT01923298 2022-02-10
Estradiol Levels in Patients Treated With Estring
University of Arizona
Phase 2 Completed
NCT02455453 2020-01-14
Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography
Washington University School of Medicine
Phase 2 Completed
NCT01385280 2018-10-17
Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer
University of Arizona
Phase NA Completed
NCT02528383 2017-09-18
Trial of Vaginal Estrogen for Urogenital Symptom Relief in Women on Aromatase Inhibitors
UConn Health
Phase NA Completed
NCT00661531 2017-04-12
Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy
Georgetown University
Phase 2 Terminated
NCT00324259 2015-02-16
Study of Physiological and High Dose Estradiol in the Treatment of Hormone Receptor Positive Metastatic Breast Cancer
Washington University School of Medicine
Phase 2 Completed
NCT00003771 2013-09-20
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT01698164 2012-10-02
Multi-centre Clinical Trial on Hormone Replacement Treatment in China
Peking Union Medical College Hospital
Phase 4 Unknown